Could your pain be related to Rheumatoid Arthritis?
Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.
Having trouble identifying pills? Try the Pill Identifier
Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.
Worried about drug interactions? Use the Interactions Checker
The drug interactions tool allows you to check for drug-drug and drug-food interactions.
Discover treatment options with the new Symptom Checker
This interactive decision guide helps identify the underlying cause of common symptoms.
Custom search for Medical Transcriptionists?
Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.
Welcome to Drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.
Featured Topic Centers
- A to Z Drug List
- Drugs by Condition
- Pill Identifier
- Drug Side Effects
- Drug Dosage
- Interactions Checker
- News & Articles
- FDA Drug Alerts
- New Drug Approvals
- New Drug Applications
- Drug Imprint Codes
- International Drugs
- Drugs by Category
- Pregnancy Warnings
- Emergency Contraception
- Inactive Ingredients
- Video Center
- MedFacts Drug Information
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- MedFacts Natural Products
Nymalize
Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid/long-acting beta2 agonist (LABA) combination indicated for ...Liptruzet
Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption inhibitor combination ...
(Not yet approved)
simeprevir
Simeprevir is an investigational NS3/4A protease inhibitor in development for the treatment of chronic hepatitis C.tivozanib
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor in development for the treatment of advanced renal cell ...trametinib
Trametinib is a MEK inhibitor in development for the treatment of unresectable or metastatic melanoma with BRAF V600 mutations.
Daily Medical News
RSSNoise, Dirty Air May Be Double Whammy for the Heart
MONDAY, May 20 -- Air pollution and noise pollution both may boost the risk of heart disease, new research from Germany suggests. "Many studies have looked at air pollution, while others have looked at noise pollution," said Dr. Barbara Hoffmann, a professor of environmental epidemiology at IUF Leibniz Research Institute for Environmental Medicine and lead author of the new study. "This study...
Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study
MONDAY, May 20 -- Although many hospital intensive care units have a nighttime attending physician on staff to help improve outcomes, new research suggests this may have no clear benefit to patients. Since one-third of teaching hospitals in the United States and three-quarters of hospitals in Europe staff a nighttime physician in the ICU, the practice may unnecessarily increase health-care costs...
Favorite Music May Ease Anxiety in ICU Patients
MONDAY, May 20 -- Music can help soothe the fear and anxiety of critically ill patients who have been placed on ventilators, reducing both their stress and their need for sedatives, according to a new study. Intensive care unit (ICU) patients allowed to listen to music of their choice whenever they liked enjoyed a 36 percent reduction in their anxiety levels compared to patients not offered...
Latest Pharma Industry News
RSSFDA Approves Xofigo for Advanced Prostate Cancer
May 15, 2013 -- The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone. Prostate cancer forms in a gland in...
FDA Approves Simponi to Treat Ulcerative Colitis
May 15, 2013 -- The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis. Simponi works by blocking tumor necrosis factor (TNF), which plays an important role in causing abnormal inflammatory and immune responses. Previously approved to treat rheumatoid arthritis, psoriatic arthritis and...
FDA Approves Generic Zomig and Zomig-ZMT Tablets
May 15, 2013 -- The U.S. Food and Drug Administration today approved the first generic versions of Zomig and Zomig-ZMT tablets. Zomig (zolmitriptan) belongs to the class of drugs called triptans, and is indicated for the acute treatment of migraine with or without aura in adults. Zomig was first approved in tablet form in November 1997, and Zomig-ZMT orally disintegrating tablets followed in...
Latest Additions to Drugs.com
Recently added consumer and prescribing information: Breo Ellipta, Suvorexant, Liptruzet, Procysbi, Kcentra, Simbrinza, Sitavig, Diclegis, Dotarem, Invokana ...also see new filings.
Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu
The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents ...
Drugs.com Receives Fourth Webby Nomination!
We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The ...
Drugs.com Launches New iOS and Android Medication Guide
Today we are officially launching a new consumer tool to join other leading Drugs.com apps – the Drugs.com Medication Guide. Patients and caregivers will have instant access to their most recent personal medication records, the latest advice on drug therapy and medical conditions, and breaking health news tailored to their needs. In addition, consumers can ...
